Aims The value of additional ablation beyond pulmonary vein isolation for atrial fibrillation (AF)
ablation is unclear, especially for persistent AF. The optimal target for substrate …

Background Coronary artery disease (CAD) is highly prevalent in patients with chronic kidney
disease and is a common cause of mortality in end‐stage renal disease. Thus, patients …

Background Catheter ablation for atrial fibrillation (AF) is a proven alternative to
pharmacologic rhythm control in patients with heart failure with reduced ejection fraction (HFrEF). …

Introduction High‐power short‐duration (HPSD) ablation is a novel strategy using contact
force‐sensing catheters optimized for power‐controlled radiofrequency ablation for atrial …

Background Kidney transplant patients suffer from vascular abnormalities and high
cardiovascular event rates, despite initial improvements post-transplantation. The nature of the …

Introduction Myriad cardiovascular manifestations have been reported with COVID‐19. We
previously reported that failure of PR interval shortening with increasing heart rate (HR) in …

Mobile electrocardiogram (mECG) devices are being used increasingly, supplying recordings
to providers and providing automatic rhythm interpretation. Given the intermittent nature of …

Patients with chronic kidney disease (CKD) experience excess cardiovascular morbidity and
mortality that is unexplained by traditional cardiovascular risk factors. Vitamin D deficiency …

Background Waitlisted kidney transplant patients suffer from excess cardiovascular events.
The benefits of regular cardiac investigations, potentially harmful and expensive, are …

Background Colchicine has anti-inflammatory properties, but its utility in improving
cardiovascular outcomes has been disputed. Here, we study the impact of colchicine on …